These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9930004)

  • 1. [Hypertransaminemia and methotrexate: not always a toxic effect?].
    Montilla Morales C; López Longo FJ; Moreno Zazo M; Monteagudo Sáez I; Moreno García AC; Carreño Pérez L
    Rev Clin Esp; 1998 Dec; 198(12):822-4. PubMed ID: 9930004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
    Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A
    Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
    Ekochin LH; Manadan AM; Aggarwal R; Sequeira W; Block JA
    J Rheumatol; 2009 Sep; 36(9):2127. PubMed ID: 19738229
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis.
    Topaloğlu S; Çalık A; Kalaycı O; Çeşmecioğlu E; Çobanoğlu Ü; Uzun Y
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():95-7. PubMed ID: 24635802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
    Tugnet N; Cooper SC; Douglas KM
    Scand J Rheumatol; 2012 Mar; 41(2):163-4. PubMed ID: 22420415
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate hepatotoxicity.
    West SG
    Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transaminitis and neutropenia are rare in patients on methotrexate: evidence from a large cohort of inflammatory arthritis patients.
    Malley T; Corfield G; Fung P; Heneghan D; Kitchen J
    Rheumatology (Oxford); 2019 Nov; 58(11):2061-2062. PubMed ID: 31081042
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of methotrexate-associated hepatotoxicity.
    Bath RK; Brar NK; Forouhar FA; Wu GY
    J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible cutaneous lymphoma occurring during methotrexate therapy.
    Viraben R; Brousse P; Lamant L
    Br J Dermatol; 1996 Jul; 135(1):116-8. PubMed ID: 8776373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Elastography for Monitoring for Hepatotoxicity in Rheumatoid Arthritis Patients on Long-term Methotrexate.
    Wade SD; Yoshida EM; Carruthers MN; Weinblatt ME
    J Clin Rheumatol; 2021 Jun; 27(4):e131-e134. PubMed ID: 30106792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Untoward effects of low dose methotrexate therapy in rheumatoid arthritis].
    Kawabe Y; Eguchi K; Tsuboi M; Kita M; Tsukada T; Takashima H; Mizokami A; Kawakami A; Matsuoka N; Migita K; Nagataki S
    Ryumachi; 1996 Jun; 36(3):514-21. PubMed ID: 8779788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient increase of aminotransferases in RA patients treated with methotrexate.
    Lacki JK; Samborski W; Machiewicz SH
    Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of methotrexate.
    Chan ES; Cronstein BN
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S5-8. PubMed ID: 24219035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
    Vincent S; Slease RB; Rocca PV
    Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.